首页> 外文OA文献 >CD4⁺CD25⁺ T cells alloactivated ex vivo by IL-2 or IL-4 become potent alloantigen-specific inhibitors of rejection with different phenotypes, suggesting separate pathways of activation by Th1 and Th2 responses
【2h】

CD4⁺CD25⁺ T cells alloactivated ex vivo by IL-2 or IL-4 become potent alloantigen-specific inhibitors of rejection with different phenotypes, suggesting separate pathways of activation by Th1 and Th2 responses

机译:被IL-2或IL-4体外同种异体激活的CD4⁺CD25⁺T细胞成为有效的同种异体抗原特异性排斥反应的不同表型抑制剂,提示Th1和Th2应答的激活途径不同

摘要

CD4⁺CD25⁺Foxp3⁺ T cells are regulatory/ suppressor cells (Tregs) that include non-antigen (Ag)-specific as well as Ag-specific Tregs. How non-Ag-specific naive CD4⁺CD25⁺ Treg develop into specific Tregs is unknown. Here, we generated adaptive Tregs by culture of naive CD4⁺CD25⁺Foxp3⁺ T cells with allo-Ag and either interleukin-2 (IL-2) or IL-4. Within days, IL-2 enhanced interferon-γ receptor (Ifnγr) and Il-5 mRNA and IL-4 induced a reciprocal profile with de novo IL-5Rα and increased IFN-γ mRNA expression. Both IL-2- and IL-4-alloactivated CD4⁺CD25⁺ Tregs within 3 to 4 days of culture had enhanced capacity to induce tolerance to specific donor but not to third-party cardiac allografts. These hosts became tolerant as allografts functioned more than 250 days, with a physiologic ratio of less than 10% CD4⁺CD25⁺Foxp3⁺ T cells in the CD4⁺ population. CD4⁺CD25⁺ T cells from tolerant hosts given IL-2-cultured cells had increased Il-5 and Ifnγr mRNA. Those from hosts given IL-4-cultured cells had enhanced IL-5Rα mRNA expression and IL-5 enhanced their proliferation to donor but not third-party allo-Ag. Thus, IL-2 and IL-4 activated allo-Ag-specific Tregs with distinct phenotypes that were retained in vivo. These findings suggested that T-helper 1 (Th1) and Th2 responses activate 2 pathways of adaptive Ag-specific Tregs that mediate tolerance. We propose they be known as T-suppressor 1(Ts1)and Ts2 cells.
机译:CD4⁺CD25⁺Foxp3⁺T细胞是调节性/抑制性细胞(Treg),包括非抗原(Ag)特异性和Ag特异性Treg。非Ag特异性幼稚CD4⁺CD25⁺Treg如何发展成特定Treg是未知的。在这里,我们通过与allo-Ag和白介素2(IL-2)或IL-4一起培养天然CD4⁺CD25⁺Foxp3⁺T细胞来产生适应性Treg。在数天内,IL-2增强了干扰素-γ受体(Ifnγr)以及Il-5 mRNA和IL-4诱导了从头IL-5Rα的倒向谱,并增加了IFN-γmRNA的表达。在培养的3到4天内,IL-2-和IL-4- alloactivatedCD4⁺CD25⁺Treg均具有增强的能力,能够诱导对特定供体的耐受性,但不能诱导对第三方心脏异体移植的耐受。随着同种异体移植功能超过250天,这些宿主变得耐受,其CD4 +群体中CD4 + CD25 + Foxp3 + T细胞的生理比例低于10%。接受IL-2培养的耐受宿主的CD4⁺CD25cells T细胞的Il-5和IfnγrmRNA增加。接受了IL-4培养细胞的宿主的细胞具有增强的IL-5RαmRNA表达,而IL-5增强了它们向供体的增殖,但没有增强第三方allo-Ag的增殖。因此,IL-2和IL-4激活了具有不同表型的同种抗原特异性Treg,这些表型在体内得以保留。这些发现表明T辅助1(Th1)和Th2响应激活介导耐受性的2种自适应Ag特异性Treg途径。我们建议将它们称为T抑制子1(Ts1)和Ts2细胞。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号